Cargando…

Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies

OBJECTIVE: Based on the tenets of traditional Chinese medicine (TCM) theory, Kampo medicines were selected and applied to two cases of Churg–Strauss syndrome and Henoch–Shönlein purpura. Two vasculitis syndrome patients exhibited persistent symptoms and abnormal blood tests after treatment with conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hijikata, Yasuyo, Ikemoto, Yumiko, Kohdera, Urara
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866557/
https://www.ncbi.nlm.nih.gov/pubmed/20463826
_version_ 1782180928522551296
author Hijikata, Yasuyo
Ikemoto, Yumiko
Kohdera, Urara
author_facet Hijikata, Yasuyo
Ikemoto, Yumiko
Kohdera, Urara
author_sort Hijikata, Yasuyo
collection PubMed
description OBJECTIVE: Based on the tenets of traditional Chinese medicine (TCM) theory, Kampo medicines were selected and applied to two cases of Churg–Strauss syndrome and Henoch–Shönlein purpura. Two vasculitis syndrome patients exhibited persistent symptoms and abnormal blood tests after treatment with conventional therapies. METHODS: As the two cases had “blood stagnation” and “damps and heat” and one had a “yang deficiency” in terms of TCM theory, we applied certain selected Kampo medicines. RESULTS: In case 1, the patient presented with hypereosinophilia, venous thrombosis, pulmonary infarction, decreased platelet count, ulner nerve palsy and Raynaud’s phenomena, which led to a diminished quality of life. After starting the Kampo medicines, the patient improved quickly and recovered within 11 months. In case 2, persistent purpura, abdominal pain, and bloody feces quickly improved and disappeared after Kampo treatment. After starting the Kampo medicines, prednisolone was stopped at 21 days without any sign of relapse to date. CONCLUSION: Kampo medicines helped clear the persistent abnormal symptoms and laboratory findings of vasculitis syndromes, Churg–Strauss syndrome and Henoch–Shönlein purpura, which had responded inadequately to the conventional therapies administered.
format Text
id pubmed-2866557
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-28665572010-05-12 Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies Hijikata, Yasuyo Ikemoto, Yumiko Kohdera, Urara Int J Gen Med Short Report OBJECTIVE: Based on the tenets of traditional Chinese medicine (TCM) theory, Kampo medicines were selected and applied to two cases of Churg–Strauss syndrome and Henoch–Shönlein purpura. Two vasculitis syndrome patients exhibited persistent symptoms and abnormal blood tests after treatment with conventional therapies. METHODS: As the two cases had “blood stagnation” and “damps and heat” and one had a “yang deficiency” in terms of TCM theory, we applied certain selected Kampo medicines. RESULTS: In case 1, the patient presented with hypereosinophilia, venous thrombosis, pulmonary infarction, decreased platelet count, ulner nerve palsy and Raynaud’s phenomena, which led to a diminished quality of life. After starting the Kampo medicines, the patient improved quickly and recovered within 11 months. In case 2, persistent purpura, abdominal pain, and bloody feces quickly improved and disappeared after Kampo treatment. After starting the Kampo medicines, prednisolone was stopped at 21 days without any sign of relapse to date. CONCLUSION: Kampo medicines helped clear the persistent abnormal symptoms and laboratory findings of vasculitis syndromes, Churg–Strauss syndrome and Henoch–Shönlein purpura, which had responded inadequately to the conventional therapies administered. Dove Medical Press 2010-04-08 /pmc/articles/PMC2866557/ /pubmed/20463826 Text en © 2010 Hijikata et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Short Report
Hijikata, Yasuyo
Ikemoto, Yumiko
Kohdera, Urara
Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies
title Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies
title_full Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies
title_fullStr Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies
title_full_unstemmed Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies
title_short Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies
title_sort kampo medicines improved blood test and qol in two vasculitis cases of churg–strauss syndrome and henoch–shönlein purpura after inadequate treatment with conventional therapies
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866557/
https://www.ncbi.nlm.nih.gov/pubmed/20463826
work_keys_str_mv AT hijikatayasuyo kampomedicinesimprovedbloodtestandqolintwovasculitiscasesofchurgstrausssyndromeandhenochshonleinpurpuraafterinadequatetreatmentwithconventionaltherapies
AT ikemotoyumiko kampomedicinesimprovedbloodtestandqolintwovasculitiscasesofchurgstrausssyndromeandhenochshonleinpurpuraafterinadequatetreatmentwithconventionaltherapies
AT kohderaurara kampomedicinesimprovedbloodtestandqolintwovasculitiscasesofchurgstrausssyndromeandhenochshonleinpurpuraafterinadequatetreatmentwithconventionaltherapies